中文名稱(chēng): 兔抗BCL9多克隆抗體
Background: |
BCL9 is associated with B-cell acute lymphoblastic leukemia. It may be a target of translocation in B-cell malignancies with abnormalities of 1q21. Its function is unknown. The overexpression of BCL9 may be of pathogenic significance in B-cell malignancies. |
Applications: |
ELISA, IHC |
Name of antibody: |
BCL9 |
Immunogen: |
Fusion protein of human BCL9 |
Full name: |
B-cell CLL/lymphoma 9 |
Synonyms: |
LGS |
SwissProt: |
O00512 |
ELISA Recommended dilution: |
5000-10000 |
IHC positive control: |
Human thyroid cancer and human cervical cancer |
IHC Recommend dilution: |
25-100 |